fig1
Figure 1. The immune microenvironment and immunotherapy for HCC. We divide current HCC immunotherapy into four categories, namely immune checkpoint inhibitors, oncolytic virus therapy, HCC vaccine and chimeric antigen receptor T (CAR-T) cell therapy. HCC: hepatocellular carcinoma
